Azithromycin in the Treatment of Community-acquired Pneumonia in Children
https://doi.org/10.22627/2072-8107-2016-15-1-45-48
Abstract
We observed 31 children aged 6 months to 6 years with community-acquired pneumonia, treated as a causal treatment of azithromycin. 20 children treated Azitroks suspension, 11 children — Sumamed suspension (control group). Results of the study showed that the efficacy and safety of the drug Azitroks suspension for the treatment of community-acquired pneumonia in children is comparable to the original drug Sumamed suspension that characterizes him as a quality domestic production of generic and can be recommended for wide use in pediatric patients.
About the Authors
N. I. Zryachkin
Saratov State Medical University, Russian Ministry of Health
Russian Federation
Doctor of Medicine, Professor, Head of the Department of Pediatrics Faculty training and retraining of specialists
Russian Federation
Doctor of Medicine, Professor, Head of the Department of Pediatrics Faculty training and retraining of specialists
S. A. Khmilevskaya
Saratov State Medical University, Russian Ministry of Health
Russian Federation
Russian Federation
O. A. Makarova
Saratov State Medical University, Russian Ministry of Health
Russian Federation
Russian Federation
M. A. Kuznetsovа
Saratov State Medical University, Russian Ministry of Health
Russian Federation
Russian Federation
E. Yu. Shcherbatyuk
Saratov State Medical University, Russian Ministry of Health
Russian Federation
Russian Federation
References
1. UNICEF/WHO. Pneumonia: The forgotten killer of children, 2006/http//whqlibdoc.who int/publications/2006/92806404889-eng.pdf
2. Мизерницкий Ю.А., Царегородцев А.Д. Пульмонология детского возраста: выпуск 11. — М.:Медпрактика, 2011. С.17. Mizernitsky Y.A., Tsaregorodcev A.D. [Childhood Pulmonary]: Issue 11. — Moscow: Medpraktika, 2011. P.17. (In Russ.)
3. Дифференциальная диагностика и терапия вирусных и вирусно-бактериальных инфекций верхних дыхательных путей у детей. URL.:http://medi.ru/Doc/149929htm [Differential diagnosis and therapy of viral and viral and bacterial infections of the upper respiratory tract in children]. URL.:http://medi.ru/Doc/149929htm (In Russ.)
4. Савенкова М.С. Многоликая острая респираторная инфекция: от основных возбудителей к выбору препаратов // Лечащий врач. 2011; 3. Savenkova M.S. [The Many Faces of acute respiratory infection from pathogens to the main drug of choice] // Therapist. 2011; 3. (In Russ.)
5. Экспертный анализ лечения острых респираторных инфекций участковыми педиатрами]. URL.:bttp://pmarchiveru/ekspertnyianaliz-lecheniya-ostryx-respiratornyx-infekcij-uchastkovymi-pediatrami/[Expert analysis of the treatment of acute respiratory infections pediatricians. URL.:bttp://pmarchiveru/ekspertnyi-analiz-lecheniyaostryx-respiratornyx-infekcij-uchastkovymi-pediatrami/ (In Russ.)
6. Таточенко В.К. Антибиотики в арсенале участкового педиатра для лечения болезней органов дыхания // Лечащий врач. 2009; 6. Tatochenko V.K. [Antibiotics in the arsenal of district pediatrician for treatment of respiratory diseases] // Therapist. 2009; 6. (In Russ.)
7. Научно-практическая программа «Внебольничная пневмония у детей: распространенность, диагностика, лечение и профилактика». — Москва, 2011. — С.19—23. [Scientific and practical program of «Community-acquired pneumonia in children: prevalence, diagnosis, treatment and prevention.»] — Moscow, 2011. — P.19—23. (In Russ.)
8. Стецюк О.У., Андреева И.В., Егорова О.А. Возможности применения азитромицина в лечении инфекций дыхательных путей у детей //Фарматека. 2012, №1. — С.1—7. Stetsyuk O.U., Andreeva I.V., Egorova O.A. Possible applications of azithromycin in the treatment of respiratory tract infections in children // Farmateka. 2012, №1. — P.1—7. (In Russ.)
9. Приказ МЗ РФ от 20 декабря 2012 г. № 1213н «Об утверждении стандарта первичной медико-санитарной помощи при пневмонии» Система ГАРАНТ: http://base.garant.ru/70340674/#ixzz3LZUZl7Rd [The Russian Ministry of Health Decree of 20 December, 2012 № 1213n «On approval of the primary health care standards in pneumonia»] System GARANT: http://base.garant.ru/70340674/#ixzz3LZUZl7Rd (In Russ.)
10. [Example of simulation for a batter understanding of PK/PD relationship of antibiotics] / Y.le. Normand, C. GaniereMonteil, H. Drugeon // Pathol.Biol. 2004. V.52. №10. Р.597—601.
11. Карпов О.И. Макролиды: новая парадигма — фармакодинамика/иммуномодуляция // Клиническая фармакология и терапия. 2005; 14 (5). (In Russ.)
12. Feldman C. et al. Inflammation. — 1997; 21: 655—665.
13. Anderson R. et al. Inflammation. — 1996; 20: 693—705.
Review
For citations:
Zryachkin N.I., Khmilevskaya S.A., Makarova O.A., Kuznetsovа M.A., Shcherbatyuk E.Yu. Azithromycin in the Treatment of Community-acquired Pneumonia in Children. CHILDREN INFECTIONS. 2016;15(1):45-48. (In Russ.) https://doi.org/10.22627/2072-8107-2016-15-1-45-48
Views:
1305
Email this article 